Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             100 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of lung cancer and hypercoagulability, complicated by suspected heparin-induced thrombocytopenia Konala, Venu Madhav
2011
5 p. 233-236
4 p.
artikel
2 Adding bevacizumab to our protocols has improved patient outcomes with little added risk Hartman, Andrea
2007
5 p. 298-
1 p.
artikel
3 An EMR story Henry, David H.
2007
5 p. 313-
1 p.
artikel
4 A new asparaginase option for ALL Atallah, Ehab
2012
5 p. 145-
1 p.
artikel
5 Angiogenic inhibitors: a fourth modality of anticancer therapy Folkman, Judah
2007
5 p. 296-298
3 p.
artikel
6 A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer Mani, Aruna
2011
5 p. 209-215
7 p.
artikel
7 A plea for new coding Neltner, Martin E.
2010
5 p. 229-231
3 p.
artikel
8 Ask your lawyer Doty, Lee W.
2006
5 p. 289-290
2 p.
artikel
9 Better communication with minority patients: seven strategies for achieving cultural competency Patten Jr., Carl W.
2006
5 p. 295-299
5 p.
artikel
10 Better margins, better quality: seizing the moment Gosfield, Alice G.
2005
5 p. 441-444
4 p.
artikel
11 Bevacizumab: antiangiogenesis success story Abraham, Jame
2007
5 p. 290-292
3 p.
artikel
12 Bevacizumab's role in treating advanced colorectal cancer Jones, Matthew P.
2007
5 p. 295-296
2 p.
artikel
13 Board-certified oncology pharmacists: partners in the multidisciplinary care of cancer patients Stull, Dawn Marie
2006
5 p. 284-286
3 p.
artikel
14 Brain metastasis from non-small cell lung cancer: sustained response with erlotinib Velagapudi, Venu
2009
5 p. 203-204
2 p.
artikel
15 CAP is not the answer Okon, Ted
2005
5 p. 454-455
2 p.
artikel
16 Choosing, installing, and supporting an EMR system Tarr, Peter J.
2007
5 p. 316-318
3 p.
artikel
17 Clinical and administrative issues: keeping current, changing hats Schwartzberg, Lee S.
2007
5 p. 270-
1 p.
artikel
18 Clinical trial awareness, attitudes, and participation among patients with cancer and oncologists Fenton, Laurie
2009
5 p. 207-213
7 p.
artikel
19 Combining sorafenib with chemoembolization for hepatocellular cancer Choi, Minsig
2011
5 p. 216-219
4 p.
artikel
20 Community experience Balalian, Steve
2005
5 p. 438-439
2 p.
artikel
21 Counseling patients on pregnancy after breast cancer: arming yourself with the facts Bosserman, Linda D.
2007
5 p. 347-348
2 p.
artikel
22 Creating a community-based, patient-centered cancer survivorship program Fisher, Robert E.
2012
5 p. 171-173
3 p.
artikel
23 Crossing the digital Rubicon: committing to electronic medical record systems Tarr, Peter J.
2007
5 p. 311-314
4 p.
artikel
24 Degarelix, a new GnRH antagonist, in prostate cancer Abraham, Jame
2009
5 p. 197-199
3 p.
artikel
25 Degarelix: medical castration without fare Gulley, James L.
2009
5 p. 199-200
2 p.
artikel
26 Detecting asymptomatic endometrial carcinoma by combined PET/CT English, Cynthia A.
2006
5 p. 246-
1 p.
artikel
27 Developing a hazardous drug safe-handling program Polovich, Martha
2005
5 p. 403-405
3 p.
artikel
28 Doing well by doing good Schwartzberg, Lee S.
2005
5 p. 375-
1 p.
artikel
29 Duodenal somatostatinoma and gastrointestinal stromal tumor associated with neurofibromatosis Sullivan, Susan Kruse
2006
5 p. 266-270
5 p.
artikel
30 Emotional distress in patients with cancer: the sixth vital sign Bultz, Barry D.
2006
5 p. 311-314
4 p.
artikel
31 Emperipolesis in giant cell carcinoma of the lung Usmani, Saad Z.
2010
5 p. 233-235
3 p.
artikel
32 Endometrial adenocarcinoma with idiopathic thrombocytopenic purpura treated without chemotherapy or irradiation Nojima, Tomoko
2008
5 p. 258-260
3 p.
artikel
33 Erwinia asparaginase for acute lymphoblastic leukemia in children with hypersensitivity to E coli-derived asparaginase Abraham, Jame
2012
5 p. 146-147
2 p.
artikel
34 Estimation of the incidence of febrile neutropenia in women receiving docetaxel plus cyclophosphamide as adjuvant therapy for early-stage breast cancer: a large community-based retrospective study Bordoni, Rodolfo Eduardo
2012
5 p. 158-164
7 p.
artikel
35 Evaluating adjuvant hormonal therapy in early-stage breast cancer: a comparison of predictive decision models Rivera, Edgardo
2007
5 p. 277-282
6 p.
artikel
36 Facing reality: cancer clinics and the full impact of MMA Coplon, Steven M.
2006
5 p. 317-318
2 p.
artikel
37 Feeding your software-hungry PDA Fried, John J.
2006
5 p. 301-302
2 p.
artikel
38 Fertility and breast cancer: the issues Theriault, Richard L.
2007
5 p. 337-338
2 p.
artikel
39 Finding programs to help patients pay for drugs is now much easier Vanchieri, Cori
2005
5 p. 410-
1 p.
artikel
40 First-year EMR check-up 2007
5 p. 322-
1 p.
artikel
41 For CMS, The definition of ‘meaningful’ Young, Patrick
2010
5 p. 240-
1 p.
artikel
42 Health-resource utilization attributable to skeletal-related events in patients with advanced cancers associated with bone metastases: results of the US cohort from a multicenter observational study Mahmood, Aftab
2012
5 p. 148-157
10 p.
artikel
43 Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell disease Bambrah, Ramandeep K.
2011
5 p. 237-238
2 p.
artikel
44 Identifying and reporting adverse drug events in oncology Hong, Aleta J.
2008
5 p. 255-256
2 p.
artikel
45 I hear a voice: using speech recognition systems in community practice Fried, John J.
2007
5 p. 326-
1 p.
artikel
46 Implementation of sentinel node biopsy for breast cancer in a community hospital Avisar, Eli
2008
5 p. 271-273
3 p.
artikel
47 Importance of molecular confirmation in the diagnosis of myeloproliferative disorders Slater, Dennis
2005
5 p. 418-422
5 p.
artikel
48 I-SPY 2: a new path for clinical trials Schwartzberg, Lee S.
2010
5 p. 225-227
3 p.
artikel
49 Ixabepilone: a new treatment option for resistant metastatic breast cancer Cleere, Darrel W.
2009
5 p. 219-226
8 p.
artikel
50 Lymphedema: ‘It has changed everything I do’ Domont, Martha
2006
5 p. 307-308
2 p.
artikel
51 Lymphoma with effusion in an HIV patient Van-Horne, Simone
2005
5 p. 429-433
5 p.
artikel
52 Making it BIG Vanchieri, Cori
2005
5 p. 453-454
2 p.
artikel
53 Making quality care transparent with EMR 2007
5 p. 321-
1 p.
artikel
54 Managing lymphedema, a lingering problem for breast cancer patients Cohen, Sara
2006
5 p. 304-307
4 p.
artikel
55 Many groups, many factors: analysis of variance Norman, Geoffrey R.
2010
5 p. 237-239
3 p.
artikel
56 New legislation would add pay for planning services Finkelstein, Joel B.
2007
5 p. 301-302
2 p.
artikel
57 New multigene assay offers valuable insight into predicting tumor behavior Babkowski, Robert C.
2010
5 p. 200-201
2 p.
artikel
58 Occurrence of immune thrombocytopenic purpura in patients with nonhematologic cancers: a systematic review of clinical evidence from case reports Tfayli, Arafat
2008
5 p. 260-263
4 p.
artikel
59 Oncotype DX assay for predicting recurrence of stage II colon cancer Abraham, Jame
2010
5 p. 198-199
2 p.
artikel
60 One process, two perspectives Curley, Brendan
2012
5 p. 174-
1 p.
artikel
61 Our first 5 years Schwartzberg, Lee S.
2009
5 p. 191-
1 p.
artikel
62 Patients' and families' receptivity to discussions about future healthcare Stearns, Lisa
2005
5 p. 446-451
6 p.
artikel
63 Practice-hospital partnerships: a marriage made for patients Leah,
2008
5 p. 245-247
3 p.
artikel
64 Pregnancy after breast cancer Alkhouri, Nabiel
2007
5 p. 331-334
4 p.
artikel
65 Radiation therapy for cutaneous melanoma: 2008 update Read, Paul W.
2008
5 p. 236-240
5 p.
artikel
66 Rare case of renal cell carcinoma presenting as a cutaneous horn Zhou, Louise
2011
5 p. 230-232
3 p.
artikel
67 Recurrent non–small-cell lung cancer in elderly patients: a case-based review of current clinical practice Ruiz, Marco
2012
5 p. 165-170
6 p.
artikel
68 Reducing the risk of recurrence in postmenopausal women with early breast cancer: a role for aromatase inhibitors Robert, Nicholas J.
2006
5 p. 275-281
7 p.
artikel
69 Results of our EMR survey: what readers told us Geffner, Edwin S.
2005
5 p. 425-426
2 p.
artikel
70 Safeguarding patients and avoiding medical errors in chemotherapy infusion suites Dohse, Linda K.
2008
5 p. 250-252
3 p.
artikel
71 Sentinel node biopsy: a community standard Spivack, Brian
2008
5 p. 274-
1 p.
artikel
72 Spotting the time bombs in your managed care contracts Fedor, Frank
2005
5 p. 435-438
4 p.
artikel
73 Staying the course Henry, David H.
2008
5 p. 277-278
2 p.
artikel
74 Taking the team approach Schwartzberg, Lee S.
2006
5 p. 234-
1 p.
artikel
75 Telephone contacts between triage nurses and cancer patients: an integral part of a community oncology practice Lucia, Victoria C.
2007
5 p. 350-353
4 p.
artikel
76 Telephone management: a reimbursable expense? Bosserman, Linda D.
2007
5 p. 354-
1 p.
artikel
77 Testing for EGFR mutations: an emerging strategy for selecting treatment for adenocarcinoma of the lungs Sequist, Lecia Van Dam
2009
5 p. 204-206
3 p.
artikel
78 The adverse health effects of occupational exposure to hazardous drugs Martin, Susan
2005
5 p. 397-400
4 p.
artikel
79 The cancer marathon: realistic perspectives on the latest science and evolving delivery systems Bosserman, Linda D.
2012
5 p. 143-144
2 p.
artikel
80 The first FDA-approved treatment for anthracycline extravasation: bringing Totect onboard, and paying for it Brutico, Carla
2008
5 p. 231-232
2 p.
artikel
81 The high cost of low-priced cancer drugs Holcombe, Dawn
2005
5 p. 408-
1 p.
artikel
82 The House hears SGR alternatives, vows action Correa, Frances
2011
5 p. 239-240
2 p.
artikel
83 The impact of first and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy in community practice: interim results of the prospective FIRST study Ozer, Howard
2006
5 p. 259-264
6 p.
artikel
84 The long path from Petri dish to patient Schwartzberg, Lee S.
2008
5 p. 218-
1 p.
artikel
85 The new era of healthcare reform Schwartzberg, Lee S.
2010
5 p. 194-
1 p.
artikel
86 The new focus on accountability Klepper, Brian
2006
5 p. 241-243
3 p.
artikel
87 The pocket-sized billing department Fried, John J.
2008
5 p. 276-
1 p.
artikel
88 There will be blood: ESA restrictions, transfusions, and cancer patients Henry, David H.
2008
5 p. 225-226
2 p.
artikel
89 The SGR by any other name… Henry, David H.
2011
5 p. 203-
1 p.
artikel
90 The value of educating patients about advance directives Schapira, Lidia
2005
5 p. 450-
1 p.
artikel
91 Three pillars of healthcare reform Dawson, Milly
2009
5 p. 237-238
2 p.
artikel
92 Totect (dexrazoxane) for treatment of anthracycline extravasation Abraham, Jame
2008
5 p. 229-230
2 p.
artikel
93 Trastuzumab in adjuvant therapy for early-stage breast cancer Tucker, Steven J.
2005
5 p. 388-390
3 p.
artikel
94 Treatment choice between GnRH receptor agonists and antagonists for advanced prostate cancer Ning, Yang-Min
2009
5 p. 200-201
2 p.
artikel
95 Triple-negative breast cancer: a clinical update Cleere, Darrel W.
2010
5 p. 203-211
9 p.
artikel
96 Understanding meta-analysis Streiner, David L.
2009
5 p. 232-235
4 p.
artikel
97 Update on paraneoplastic neurologic disorders Dalmau, Josep
2010
5 p. 219-224
6 p.
artikel
98 Update on romiplostim therapy for immune thrombocytopenic purpura Stenger, Matt
2011
5 p. 224-228
5 p.
artikel
99 Why we need a new prognostic test for colon cancer Schwartzberg, Lee S.
2010
5 p. 199-200
2 p.
artikel
100 Your open line to the CMS Schwartzberg, Lee S.
2005
5 p. 379-382
4 p.
artikel
                             100 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland